ArticleThe AAPS journal2020

A Novel Pharmacodynamic Biomarker and Mechanistic Modeling Facilitate the Development of Tovetumab, a Monoclonal Antibody Directed Against Platelet-Derived Growth Factor Receptor Alpha, for Cancer Therapy.

Meina Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.